CPTCF (Cytophage Technologies) Accounts Payable: $0.23 Mil (As of Dec. 2025)


CPTCF Cytophage Technologies Ltd CPTCF
18 GF Score
Price $0.21
! 1 Warning Sign
View Full Analysis

What is Cytophage Technologies Accounts Payable?

Cytophage Technologies CPTCF 18 Accounts Payable is $0.23 Mil as of Dec. 2025. GuruFocus rates CPTCF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Cytophage Technologies's Accounts Payable for the quarter that ended in Dec. 2025 was $0.23 Mil.

Cytophage Technologies's quarterly Accounts Payable increased from Jun. 2025 ($0.23 Mil) to Sep. 2025 ($0.31 Mil) but then declined from Sep. 2025 ($0.31 Mil) to Dec. 2025 ($0.23 Mil).

Cytophage Technologies's annual Accounts Payable declined from Dec. 2023 ($0.27 Mil) to Dec. 2024 ($0.15 Mil) but then increased from Dec. 2024 ($0.15 Mil) to Dec. 2025 ($0.23 Mil).

Cytophage Technologies Accounts Payable Related Terms

Cytophage Technologies Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Accounts Payable Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.01 0.08 0.27 0.15 0.23

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.22 0.23 0.31 0.23
CPTCF
18GF Score
Cytophage Technologies Ltd CPTCF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytophage Technologies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.23 Mil mean?
Cytophage Technologies (CPTCF) has a Accounts Payable of $0.23 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cytophage Technologies and its competitors.
Is Cytophage Technologies' Accounts Payable too high?
Cytophage Technologies' current Accounts Payable is $0.23 Mil. Overall, Cytophage Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cytophage Technologies' Accounts Payable compare to VRTX and REGN?
Cytophage Technologies' Accounts Payable of $0.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Accounts Payable is $0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (CPTCF) has a current Accounts Payable of $0.23 Mil. The current Accounts Payable is $0.23 Mil. Cytophage Technologies' overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cytophage Technologies (CPTCF), the current Accounts Payable is $0.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Other Exchanges CYTO.H:Canada
Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.
18GF Score

Get the complete analysis for CPTCF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price